Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract

Current Oncology Reports

Volumn 7, Issue 6, 2005, Pages 435-443

  Frumovitz, Michael ^a   Ramirez, Pedro T ^a   Levenback, Charles ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER LOCALIZATION; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; FEMALE GENITAL TRACT CANCER; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LABORATORY DIAGNOSIS; LAPAROSCOPY; LAPAROTOMY; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; PELVIS LYMPH NODE; PROGNOSIS; RADICAL HYSTERECTOMY; RADIOSENSITIVITY; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CARCINOMA;

EID: 28044445111     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-005-0008-y     Document Type: Review

References (52)

1. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 1977, 39:456-466.
2. Uren RF, Howman-Giles R, Thompson JF: Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003, 44:570-582.
3. Morton DL, Thompson JF, Essner R, et al.: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999, 230:453-463.
4. Sanidas EE, de Bree E, Tsiftsis DD: How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg 2003, 185:202-210.
5. Cancer statistics, 2005. Cancer 2005, 55:10-30.
6. Lu KH, Burke TW: Early cervical cancer. Curr Treat Options Oncol 2000, 1:147-155.
7. Berek J, Hacker N: Practical Gynecologic Oncology, edn 3. Baltimore: Lippincott Williams & Wilkins; 2000.
8. Burke TW: Treatment options in stage IB cervical cancer: radical hysterectomy and radiotherapy. Semin Radiat Oncol 1994, 4:34-40.
9. O'Boyle JD, Coleman RL, Bernstein SG, et al.: Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000, 79:238-243.
10. Marchiole P, Buenerd A, Scoazec JY, et al.: Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 2004, 100:2154-2159.
11. Malur S, Krause N, Kohler C, Schneider A: Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol 2001, 80:254-257.
12. Martinez-Palones JM, Gil-Moreno A, Perez-Benavente MA, et al.: Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol 2004, 92:845-850.
13. Dargent D, Enria R: Laparoscopic assessment of the sentinel lymph nodes in early cervical cancer. Technique-preliminary results and future developments. Crit Rev Oncol Hematol 2003, 48:305-310.
14. Angioli R, Palaia I, Cipriani C, et al.: Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol 2005, 96:504-509.
15. Lin YS, Tzeng CC, Huang KF, et al.: Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer. Int J Gynecol Cancer 2005, 15:273-277.
16. van Dam PA, Hauspy J, Vanderheyden T, et al.: Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer 2003, 13:182-186.
17. Silva LB, Silva-Filho AL, Traiman P, et al.: Sentinel node detection in cervical cancer with (99m)Tc-phytate. Gynecol Oncol 2005, 97:588-595.
18. Rhim CC, Park JS, Bae SN, Namkoong SE: Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer. J Korean Med Sci 2002, 17:507-511.
19. Levenback C, Coleman RL, Burke TW, et al.: Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002, 20:688-693.
20. Buist MR, Pijpers RJ, van Lingen et al.: Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol 2003, 90:290-296.
21. Barranger E, Cortez A, Uzan S, et al.: Value of intraoperative imprint cytology of sentinel nodes in patients with cervical cancer. Gynecol Oncol 2004, 94:175-180.
22. Plante M, Renaud MC, Tetu B, et al.: Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 2003, 91:494-503.
23. Wydra D, Sawicki S, Bandurski T: The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur J Nucl Med Mol Imaging 2005, 32:720-721.
24. Niikura H, Okamura C, Akahira J, et al.: Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol Oncol 2004, 94:528-532.
25. Frumovitz M, Coleman RL, Gayed IW, et al.: Utility of preoperative lymphoscintigraphy in patients undergoing radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol 2005, in press.
26. Rahusen FD, Torrenga H, van Diest PJ, et al.: Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001, 136:1059-1063.
27. Reynolds C, Mick R, Donohue JH, et al.: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999, 17:1720-1726.
28. Kamath VJ, Giuliano R, Dauway EL, et al.: Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001, 136:688-692.
29. Barranger E, Coutant C, Cortez A, Uzan S, Darai E: Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease. Ann Oncol 2005, 16:1237-1242.
30. Thevarajah S, Huston TL, Simmons RM: A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005, 189:236-239.
31. Coleman RL, Whitten CW, O'Boyle J, Sidhu B: Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure. J Surg Oncol 1999, 70:126-129.
32. Hoskins WJ, Perez CA, Young RC: Principles and Practice of Gynecologic Oncology, edn 3. Baltimore: Lippincott Williams & Wilkins; 2000.
33. Rodier JF, Janser JC, David E, et al.: Radiopharmaceutical-guided surgery in primary malignant melanoma of the vagina. Gynecol Oncol 1999, 75:308-309.
34. van Dam P, Sonnemans H, van Dam PJ, et al.: Sentinel node detection in patients with vaginal carcinoma. Gynecol Oncol 2004, 92:89-92.
35. Abramova L, Parekh J, Irvin WP Jr, et al.: Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review. Ann Surg Oncol 2002, 9:840-846.
36. Nakagawa S, Koga K, Kugu K, et al.: The evaluation of the sentinel node successfully conducted in a case of malignant melanoma of the vagina. Gynecol Oncol 2002, 86:387-389.
37. Levenback C, Coleman RL, Burke TW, et al.: Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001, 83:276-281.
38. Ansink AC, Sie-Go DM, van der Velden J, et al.: Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer 1999, 86:652-656.
39. de Hullu JA, Hollema H, Piers DA, et al.: Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000, 18:2811-2816.
40. Moore RG, Granai CO, Gajewski W, et al.: Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol 2003, 91:378-382.
41. Sliutz G, Reinthaller A, Lantzsch T, et al.: Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol 2002, 84:449-452.
42. De Cicco C, Sideri M, Bartolomei M, et al.: Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000, 82:295-299.
43. Sideri M, De Cicco C, Maggioni A, et al.: Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori 2000, 86:359-363.
44. Puig-Tintore LM, Ordi J, Vidal-Sicart S, et al.: Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 2003, 88:29-34.
45. de Hullu JA, Hollema H, Hoekstra HJ, et al.: Vulvar melanoma: Is there a role for sentinel lymph node biopsy?. Cancer 2002, 94:486-491.
46. Frumovitz M, Ramirez PT, Tortolero-Luna G, et al.: Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol 2004, 92:205-210.
47. Louis-Sylvestre C, Evangelista E, Leonard F, et al.: Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol Oncol 2005, 97:151-154.
48. de Hullu JA, Oonk MH, Ansink AC, et al.: Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol 2004, 94:10-15.
49. Levavi H, Sabah G, Hardoff R, et al.: Failure of sentinel node identification following neo-adjuvant chemo-radiotherapy for locally advanced squamous cell carcinoma of the vulva. Eur J Gynaecol Oncol 2003, 24:433-434.
50. Fons G, ter Rahe B, Sloof G, et al.: Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node. Gynecol Oncol 2004, 92:981-984.
51. Terada KY, Shimizu DM, Wong JH: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000, 76:40-44.
52. Tamussino KF, Bader AA, Lax SF, et al.: Groin recurrence after micrometastasis in a sentinel lymph node in a patient with vulvar cancer. Gynecol Oncol 2002, 86:99-101.